US Patent Issued to Tianjin University on July 14 for "Theranostic probe and its use for targeting and/or labeling the EGFR kinase and/or the cells expressing EGFR or its family members" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,518, issued on July 14, was assigned to Tianjin University (Tianjin, China).

"Theranostic probe and its use for targeting and/or labeling the EGFR kinase and/or the cells expressing EGFR or its family members" was invented by Lizhi Mi (Tianjin, China), Xingxing Wang (Tianjin, China), Peng Liu (Tianjin, China), Xiaohong Qin (Tianjin, China) and Zhiqun Shang (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application is directed to a theranostic probe and its use for targeting and/or labeling the EGFR kinase and/or the cells expressing EGFR or its family members."

The patent was filed on Feb. 21, 2020, under Application No....